Dobutamine
- Product NDC
- 0143-9141
- 11-digit product format
- 001439141
- Labeler code
- 0143
- Product ID
- 0143-9141_b0a40444-634c-4eb0-a861-fe9e21e02552
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dobutamine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA074277
- Marketing category
- ANDA
- Marketing start
- 2023-05-03
- Substance
- DOBUTAMINE HYDROCHLORIDE
- Active strength
- 12.5 mg/mL
- Pharmacologic classes
- Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0WR771DJXV | DOBUTAMINE HYDROCHLORIDE | 49745-95-1 | DOBUTAMINE HYDROCHLORIDE |
| 3S12J47372 | DOBUTAMINE | 34368-04-2 | Dobutamine |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0143-9141-10 | 00143914110 | 10 VIAL in 1 CARTON (0143-9141-10) / 20 mL in 1 VIAL | 10 vial | 2023-05-03 | No | No | Historical |